−0KRW
−164.04 MKRW
52.81 BKRW
66.77 M
About HLBBIOSTEP
Sector
Headquarters
Inchon
Website
Employees (FY)
174
Founded
2012
ISIN
KR7278650007
FIGI
BBG00QKHL3L9
HLB bioStep Co., Ltd. engages in the provision of clinical research services. It provides non-clinical experiments on newly developed substances such as new drugs. The company was founded on April 19, 2012 and is headquartered in Incheon, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 278650 is 3835 KRW — it has decreased by 0.39% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HLBBIOSTEP stocks are traded under the ticker 278650.
278650 stock is 2.11% volatile and has beta coefficient of 1.78. Check out the list of the most volatile stocks — is HLBBIOSTEP there?
HLBBIOSTEP revenue for the last quarter amounts to 14.60 B KRW despite the estimated figure of 17.80 B KRW. In the next quarter revenue is expected to reach 19.80 B KRW.
Yes, you can track HLBBIOSTEP financials in yearly and quarterly reports right on TradingView.
278650 stock has risen by 1.99% compared to the previous week, the month change is a 1.67% fall, over the last year HLBBIOSTEP has showed a 22.99% decrease.
278650 net income for the last quarter is 781.89 M KRW, while the quarter before that showed −1.71 B KRW of net income which accounts for 145.82% change. Track more HLBBIOSTEP financial stats to get the full picture.
Today HLBBIOSTEP has the market capitalization of 316.36 B, it has decreased by 1.72% over the last week.
Like other stocks, 278650 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HLBBIOSTEP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 174.00 employees. See our rating of the largest employees — is HLBBIOSTEP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HLBBIOSTEP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HLBBIOSTEP stock shows the neutral signal. See more of HLBBIOSTEP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HLBBIOSTEP EBITDA is 2.29 B KRW, and current EBITDA margin is 4.34%. See more stats in HLBBIOSTEP financial statements.